Targeted therapy of gastrointestinal cancer using human anti-CEA antibody
Targeted therapy of gastrointestinal cancer using human anti-CEA antibody
批准号:
17591421
负责人:
TANAKA Toshihiro
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We constructed a fiber modified Ad5 vector (Adv-FZ33) in which an IgG-binding domain (Z33) derived from staphylococcal protein A was inserted into the HI loop of knob protein. We evaluated on both in vitro and in vivo levels the extent of retargeting towards and therapeutic effectiveness against CEA-positive gastric cancers when using the anti-CEA antibody complex with this modified vector. In vitro LacZ gene expression after infection with Adv-FZ33 vectors conjugated to anti-CEA mAb was approximately 20 times higher than that obtained with vector conjugated to the control mAb. We generated Ax3CAUP-FZ33, which is an Adv-FZ33 derivative vector expressing a therapeutic gene, namely E. coli uracil phosphoribosyltransferase (UPRT) which converts 5FU directly to 5-fluorouridine monophosphate. When conjugated with the anti-CEA mAb, Ax3CAUP-FZ33 enhanced the cytotoxicity of 5FU (19.7-fold in terms of IC_<50> values) against gastric cancer cells. Nextl, we examined the survival effects of Ax3U … More P-FZ33 conjugated with anti-CEA mAb plus 5FU in mice with peritoneal disseminated gastric cancer. The median survival time of the Ax3CAUP-FZ33/anti-CEA mAb/5FU group was significantly longer than those of the PBS and 5FU only treatment groups (p<0.01, versus PBS and 5FU only groups).Furthermore, we examined which subtype of IgG was effective on gene delivery mediated by Adv-FZ33 and anti-CEA mAb. BIACORE analysis showed that human IgG1 and IgG4 had 1,000-fold higher affinity constants (Ka) for protein A compared with mouse IgG1, whereas only 10-fold higher than mouse IgG2a or IgG3. In CEA-expressing cells, the transgene expression using Adv-FZ33 and any subtype of anti-CEA human IgG was significantly increased compared with combinations of any type of virus-anti-CEA mouse IgG. Especially, human IgG4 mediated transduction efficiency showed 200-fold enhancements compared with mouse IgG1. We found that the reactivity of Ab and protein A played a key role in the Ab dependent gene delivery by Adv-FZ33. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
将细胞毒性 T 淋巴细胞和/或自然杀伤细胞重新靶向具有抗 CEA 抗体活性的表达 CEA 的肿瘤细胞。
DOI:
--
发表时间:
2005
期刊:
Anticancer Res. 25(6)
影响因子:
--
作者:
[Kuroki, Ma., Hachimine, K., Huang J., Shibaguchi, H., Kinugasa, T., Maekawa, S., Kuroki, Mo.]
通讯作者:
Mo.
Recent Development in Gene Therapy
基因治疗的最新进展
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Tanaka T, Hamada H, Kuroki Ma, et al.]
通讯作者:
et al.
Targeting of cancer gene therapy with antibodies or their genes against tumor-associated antigens.
使用抗肿瘤相关抗原的抗体或其基因来靶向癌症基因治疗。
DOI:
--
发表时间:
2005
期刊:
Gene Ther.Mol.Biol. 9
影响因子:
--
作者:
[田中純子, 片山恵子, Kuroki M.]
通讯作者:
Kuroki M.
Targeting of cacner gene therapy with antibodies or their genes against tumor-associated antigens.
使用抗肿瘤相关抗原的抗体或其基因来靶向癌症基因治疗。
DOI:
--
发表时间:
2005
期刊:
Gene Ther. Mol. Biol. 9(A)
影响因子:
--
作者:
[Kuroki Ma, et al.]
通讯作者:
et al.
Bcl-xL gene transfer inhibits Bax translocation and prolongs cardiac cold preservation time in rat.
Bcl-xL 基因转移抑制 Bax 易位并延长大鼠心脏冷藏时间。
DOI:
--
发表时间:
2005
期刊:
Circulation 112
影响因子:
--
作者:
[Huang J, Hamada H et al.]
通讯作者:
Hamada H et al.
共 12 条
IL-35 associate with the Th2 response and the differentiation of Tregs in type 1 AIP.
-
批准号:19K17476
-
项目类别:Grant-in-Aid for Early-Career Scientists
-
资助金额:$2.75万
-
财政年份:2019
-
负责人:TANAKA Toshihiro
-
依托单位:
Mechanism elucidation of interfacial tension change due to chemical reaction between molten iron and molten slag and construction of quantitative estimation model
-
批准号:17H03437
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2017
-
负责人:TANAKA Toshihiro
-
依托单位:
Design of a process producing joint materials by using surface porous gradient structure
-
批准号:22656173
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.26万
-
财政年份:2010
-
负责人:TANAKA Toshihiro
-
依托单位:
Pancreas-specific antibody production and development of pancreatic cancer therapy using virus vector
-
批准号:22501054
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2010
-
负责人:TANAKA Toshihiro
-
依托单位:
Development of experimental procedure for interfacial Gibbs energy between solid and liquid phases in alloy systems of nano particles.
-
批准号:21360370
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2009
-
负责人:TANAKA Toshihiro
-
依托单位:
Evaluation of interfacial energies to make phase diagrams of nano-sized particles for alloys
-
批准号:18360368
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.96万
-
财政年份:2006
-
负责人:TANAKA Toshihiro
-
依托单位:
Architecture of Thermodynamic Databases for Evaluation of Nano-size Alloys Phase Diagrms
-
批准号:14550724
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:TANAKA Toshihiro
-
依托单位:
Experimental Evaluation of Inter facial Segregation between Liquid Alloys and Molten Salt by using Electro-chemical Capillarity
-
批准号:12650734
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:2000
-
负责人:TANAKA Toshihiro
-
依托单位:
Molecular Dynamic Simulation of Surface Structure in Multi-component Liquids
-
批准号:09650810
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1997
-
负责人:TANAKA Toshihiro
-
依托单位:
Construction of a transgenicmouse bearing pathogenic antibody to pemphigoid
-
批准号:09670877
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1997
-
负责人:TANAKA Toshihiro
-
依托单位:
The Formation of J.B.Clark's economics and American Sociology : A Study of the Correspondence between J.B.Clark and F.H.Giddings.
-
批准号:08630017
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:1996
-
负责人:TANAKA Toshihiro
-
依托单位:
Construction of databases on surface tension of multi-component liquid alloys and molten oxides
-
批准号:07650872
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:TANAKA Toshihiro
-
依托单位:
An animal model for keratosis
-
批准号:07557348
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$2.05万
-
财政年份:1995
-
负责人:TANAKA Toshihiro
-
依托单位:
Isolation and characterization of the epidermolysis bullosa acquisita antigei
-
批准号:04670640
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1992
-
负责人:TANAKA Toshihiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于 CeA-DMV-Vagus 环路研究电针刺激四关穴缓解帕金森病的作用机 制
-
批准号:JCZRLH202600541
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基底外侧杏仁核敏化介导PVT-CeA神经环路长时程增强参与失眠慢性化的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:高东
-
依托单位:
Eph-Ephrin 信号通路通过调控 PVT→CeA 神经环路干预双相情感障碍共病睡眠障碍发生的机制研究
-
批准号:2025JJ80610
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:朱薇薇
-
依托单位:
VTA-CeA-LC神经环路调控应激性睡眠启动障碍
-
批准号:2024Y9225
-
项目类别:省市级项目
-
资助金额:40.0万元
-
批准年份:2024
-
负责人:蔡萍
-
依托单位:
柴胡疏肝散通过CeA-vIPAG 神经环路治疗疼痛-焦虑共共病的机制研究
-
批准号:2024W01002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈慕媛
-
依托单位:
杏仁核BLA(GLU)-CeA(GABA)微环路参与痛相关负性情绪发生与电针干预的机制研究
-
批准号:LY23H270009
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:吴媛媛
-
依托单位:
PVT谷氨酸能信号调控到CeA环路的突触可塑性在卒中后抑郁中的作用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:陈茜
-
依托单位:
PZ-CeA促睡眠神经环路在七氟醚麻醉镇静中的作用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:赵文玲
-
依托单位:
CeA-PCRt投射通路中GABA能神经元在心理应激致口颌肌紧张度升高中的作用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:赵雅娟
-
依托单位:
LPB—CeA胆碱能投射在METH复吸中的调控作用及机制研究
-
批准号:82071495
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:关晓伟
-
依托单位: